These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease. Raju TN; Vidyasagar D; Bhat R; Sobel D; McCulloch KM; Anderson M; Maeta H; Levy PS; Furner S Lancet; 1987 Mar; 1(8534):651-6. PubMed ID: 2882083 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of hyaline membrane disease in the preterm newborn with exogenous lung surfactant: a controlled study]. Sánchez-Mendiola M; Martínez-Natera OC; Herrera-Maldonado N; Ortega-Arroyo J Gac Med Mex; 2005; 141(4):267-71. PubMed ID: 16164120 [TBL] [Abstract][Full Text] [Related]
12. The late administration of surfactant. Ballot DE; Rothberg AD; Davies VA S Afr Med J; 1995 Jul; 85(7):644-6. PubMed ID: 7482080 [TBL] [Abstract][Full Text] [Related]
13. The circulation, fluid transfers and surface activity in the lungs of infants with hyaline membrane disease. Normand IC Bull Physiopathol Respir (Nancy); 1973; 9(6):1473-94. PubMed ID: 4602246 [No Abstract] [Full Text] [Related]
14. Effect of single dose surfactant on pulmonary function. Bhat R; Dziedzic K; Bhutani VK; Vidyasagar D Crit Care Med; 1990 Jun; 18(6):590-5. PubMed ID: 2111754 [TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Gitlin JD; Soll RF; Parad RB; Horbar JD; Feldman HA; Lucey JF; Taeusch HW Pediatrics; 1987 Jan; 79(1):31-7. PubMed ID: 3540835 [TBL] [Abstract][Full Text] [Related]